204 related articles for article (PubMed ID: 14592831)
1. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry.
Markovic I; Stantchev TS; Fields KH; Tiffany LJ; Tomiç M; Weiss CD; Broder CC; Strebel K; Clouse KA
Blood; 2004 Mar; 103(5):1586-94. PubMed ID: 14592831
[TBL] [Abstract][Full Text] [Related]
2. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
Barbouche R; Miquelis R; Jones IM; Fenouillet E
J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
[TBL] [Abstract][Full Text] [Related]
3. Progress in targeting HIV-1 entry.
Ryser HJ; Flückiger R
Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry.
Gallina A; Hanley TM; Mandel R; Trahey M; Broder CC; Viglianti GA; Ryser HJ
J Biol Chem; 2002 Dec; 277(52):50579-88. PubMed ID: 12218051
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env.
Barbouche R; Lortat-Jacob H; Jones IM; Fenouillet E
Mol Pharmacol; 2005 Apr; 67(4):1111-8. PubMed ID: 15644496
[TBL] [Abstract][Full Text] [Related]
7. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120.
Reiser K; François KO; Schols D; Bergman T; Jörnvall H; Balzarini J; Karlsson A; Lundberg M
Int J Biochem Cell Biol; 2012 Mar; 44(3):556-62. PubMed ID: 22230366
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics.
Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251
[TBL] [Abstract][Full Text] [Related]
10. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding.
Fenouillet E; Barbouche R; Courageot J; Miquelis R
J Infect Dis; 2001 Mar; 183(5):744-52. PubMed ID: 11181151
[TBL] [Abstract][Full Text] [Related]
11. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
12. Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.
Gallo SA; Reeves JD; Garg H; Foley B; Doms RW; Blumenthal R
Retrovirology; 2006 Dec; 3():90. PubMed ID: 17144914
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in understanding the molecular mechanisms of HIV-1 entry and fusion: revisiting current targets and considering new options for therapeutic intervention.
Markovic I; Clouse KA
Curr HIV Res; 2004 Jul; 2(3):223-34. PubMed ID: 15279586
[TBL] [Abstract][Full Text] [Related]
14. Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase.
Papandréou MJ; Barbouche R; Guieu R; Rivera S; Fantini J; Khrestchatisky M; Jones IM; Fenouillet E
J Biol Chem; 2010 Apr; 285(18):13788-96. PubMed ID: 20202930
[TBL] [Abstract][Full Text] [Related]
15. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
Chabot DJ; Zhang PF; Quinnan GV; Broder CC
J Virol; 1999 Aug; 73(8):6598-609. PubMed ID: 10400757
[TBL] [Abstract][Full Text] [Related]
16. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
[TBL] [Abstract][Full Text] [Related]
17. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
[TBL] [Abstract][Full Text] [Related]
18. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
Alsahafi N; Debbeche O; Sodroski J; Finzi A
PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
[TBL] [Abstract][Full Text] [Related]
19. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2001 Nov; 75(22):11096-105. PubMed ID: 11602749
[TBL] [Abstract][Full Text] [Related]
20. CD4-induced T-20 binding to human immunodeficiency virus type 1 gp120 blocks interaction with the CXCR4 coreceptor.
Yuan W; Craig S; Si Z; Farzan M; Sodroski J
J Virol; 2004 May; 78(10):5448-57. PubMed ID: 15113923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
